Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2026-01-05 @ 1:49 PM
Study NCT ID:
NCT02698735
Status:
COMPLETED
Last Update Posted:
2019-10-29
First Post:
2016-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-19
First Submit QC Date:
None
Study First Post Date:
2016-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-31
Results First Submit QC Date:
None
Results First Post Date:
2019-08-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-15
Last Update Post Date:
2019-10-29
Last Update Post Date Type:
ACTUAL